Investing News

Carl Icahn and Illumina Proxy Fight Heats Up

Biotech firm Illumina (ILMN) told shareholders not to vote for the board nominees put forward by billionaire activist investor Carl Icahn.

Articles You May Like

The 7 Best Positioned Dow Stocks for April 2024
Palantir Stock at a Crossroads: Analyzing the Risks and Rewards for Investors
Economic Factors That Affect the Forex Market
3 Tech Stock Winners to Buy Now for a Huge 2024
3 Commodities Stocks to Buy Now as Prices Heat Up